BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1122 related articles for article (PubMed ID: 26111589)

  • 1. Maternal characteristics and mid-pregnancy serum biomarkers as risk factors for subtypes of preterm birth.
    Jelliffe-Pawlowski LL; Baer RJ; Blumenfeld YJ; Ryckman KK; O'Brodovich HM; Gould JB; Druzin ML; El-Sayed YY; Lyell DJ; Stevenson DK; Shaw GM; Currier RJ
    BJOG; 2015 Oct; 122(11):1484-93. PubMed ID: 26111589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between maternal characteristics, abnormal serum aneuploidy analytes, and placental abruption.
    Blumenfeld YJ; Baer RJ; Druzin ML; El-Sayed YY; Lyell DJ; Faucett AM; Shaw GM; Currier RJ; Jelliffe-Pawlowski LL
    Am J Obstet Gynecol; 2014 Aug; 211(2):144.e1-9. PubMed ID: 24631707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine first-trimester pre-eclampsia screening and risk of preterm birth.
    Giorgione V; Quintero Mendez O; Pinas A; Ansley W; Thilaganathan B
    Ultrasound Obstet Gynecol; 2022 Aug; 60(2):185-191. PubMed ID: 35441764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of early-preterm birth with abnormal levels of routinely collected first- and second-trimester biomarkers.
    Jelliffe-Pawlowski LL; Shaw GM; Currier RJ; Stevenson DK; Baer RJ; O'Brodovich HM; Gould JB
    Am J Obstet Gynecol; 2013 Jun; 208(6):492.e1-11. PubMed ID: 23395922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preterm birth phenotypes in women with autoimmune rheumatic diseases: a population-based cohort study.
    Kolstad KD; Mayo JA; Chung L; Chaichian Y; Kelly VM; Druzin M; Stevenson DK; Shaw GM; Simard JF
    BJOG; 2020 Jan; 127(1):70-78. PubMed ID: 31571337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpregnancy interval after live birth or pregnancy termination and estimated risk of preterm birth: a retrospective cohort study.
    Shachar BZ; Mayo JA; Lyell DJ; Baer RJ; Jeliffe-Pawlowski LL; Stevenson DK; Shaw GM
    BJOG; 2016 Nov; 123(12):2009-2017. PubMed ID: 27405702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for spontaneous and provider-initiated preterm delivery in high and low Human Development Index countries: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health.
    Morisaki N; Togoobaatar G; Vogel JP; Souza JP; Rowland Hogue CJ; Jayaratne K; Ota E; Mori R;
    BJOG; 2014 Mar; 121 Suppl 1():101-9. PubMed ID: 24641540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of race/ethnicity and BMI on the association between height and risk for spontaneous preterm birth.
    Shachar BZ; Mayo JA; Lee HC; Carmichael SL; Stevenson DK; Shaw GM; Gould JB
    Am J Obstet Gynecol; 2015 Nov; 213(5):700.e1-9. PubMed ID: 26187451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and risk factors of preterm births in a tertiary center in Lagos, Nigeria.
    Butali A; Ezeaka C; Ekhaguere O; Weathers N; Ladd J; Fajolu I; Esezobor C; Makwe C; Odusanya B; Anorlu R; Adeyemo W; Iroha E; Egri-Okwaji M; Adejumo P; Oyeneyin L; Abiodun M; Badejoko B; Ryckman K
    Pan Afr Med J; 2016; 24():1. PubMed ID: 27583065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-trimester serum biomarkers in twin pregnancies and adverse obstetric outcomes-a single center cohort study.
    Queirós A; Gomes L; Pereira I; Charepe N; Plancha M; Rodrigues S; Cohen Á; Alves M; Papoila AL; Simões T
    Arch Gynecol Obstet; 2024 Jul; 310(1):315-325. PubMed ID: 38734998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal age and adverse pregnancy outcome: a cohort study.
    Khalil A; Syngelaki A; Maiz N; Zinevich Y; Nicolaides KH
    Ultrasound Obstet Gynecol; 2013 Dec; 42(6):634-43. PubMed ID: 23630102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First trimester serum analytes, maternal characteristics and ultrasound markers to predict pregnancies at risk for preterm birth.
    Stout MJ; Goetzinger KR; Tuuli MG; Cahill AG; Macones GA; Odibo AO
    Placenta; 2013 Jan; 34(1):14-9. PubMed ID: 23199792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome.
    Huang T; Hoffman B; Meschino W; Kingdom J; Okun N
    Prenat Diagn; 2010 May; 30(5):471-7. PubMed ID: 20440736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors associated with preterm birth after a prior term delivery.
    Wong LF; Wilkes J; Korgenski K; Varner MW; Manuck TA
    BJOG; 2016 Oct; 123(11):1772-8. PubMed ID: 26412012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal and neonatal epidemiological features in clinical subtypes of preterm birth.
    Gimenez LG; Krupitzki HB; Momany AM; Gili JA; Poletta FA; Campaña H; Cosentino VR; Saleme C; Pawluk M; Murray JC; Castilla EE; Gadow EC; Lopez-Camelo JS
    J Matern Fetal Neonatal Med; 2016 Oct; 29(19):3153-61. PubMed ID: 26701680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of preterm birth with and without preeclampsia using mid-pregnancy immune and growth-related molecular factors and maternal characteristics.
    Jelliffe-Pawlowski LL; Rand L; Bedell B; Baer RJ; Oltman SP; Norton ME; Shaw GM; Stevenson DK; Murray JC; Ryckman KK
    J Perinatol; 2018 Aug; 38(8):963-972. PubMed ID: 29795450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum alpha-fetoprotein in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
    Bredaki FE; Sciorio C; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Jul; 46(1):34-41. PubMed ID: 25652769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proposed method to predict preterm birth using clinical data, standard maternal serum screening, and cholesterol.
    Alleman BW; Smith AR; Byers HM; Bedell B; Ryckman KK; Murray JC; Borowski KS
    Am J Obstet Gynecol; 2013 Jun; 208(6):472.e1-11. PubMed ID: 23500456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal serum markers, characteristics and morbidly adherent placenta in women with previa.
    Lyell DJ; Faucett AM; Baer RJ; Blumenfeld YJ; Druzin ML; El-Sayed YY; Shaw GM; Currier RJ; Jelliffe-Pawlowski LL
    J Perinatol; 2015 Aug; 35(8):570-4. PubMed ID: 25927270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of combined serum biomarkers for adverse pregnancy outcomes.
    Cohen JL; Smilen KE; Bianco AT; Moshier EL; Ferrara LA; Stone JL
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():89-94. PubMed ID: 25129153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.